BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 8904243)

  • 1. [Nephrogenic diabetes insipidus].
    Ishikawa S
    Nihon Rinsho; 1996 Mar; 54(3):819-24. PubMed ID: 8904243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
    Ishikawa SE
    Nihon Rinsho; 2002 Feb; 60(2):350-5. PubMed ID: 11857925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of nephrogenic diabetes insipidus.
    Oksche A; Rosenthal W
    J Mol Med (Berl); 1998 Apr; 76(5):326-37. PubMed ID: 9587067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.
    van Os CH; Deen PM
    Proc Assoc Am Physicians; 1998; 110(5):395-400. PubMed ID: 9756089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL; Friedman E; Boson W; Moreira A; Figueiredo B; Liberman B; de Lacerda L; Sandrini R; Graf H; Martins S; Puñales MK; De Marco L
    Hum Mutat; 1999; 14(3):233-9. PubMed ID: 10477431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrogenic diabetes insipidus].
    Evrard A; Lefebvre J; Vantyghem M
    Ann Endocrinol (Paris); 1999 Dec; 60(6):457-64. PubMed ID: 10617799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK; Nielsen S; Kurtz I
    Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephrogenic diabetes insipidus].
    Ishikawa SE
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():515-21. PubMed ID: 11838161
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
    Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.
    Mulders SM; Bichet DG; Rijss JP; Kamsteeg EJ; Arthus MF; Lonergan M; Fujiwara M; Morgan K; Leijendekker R; van der Sluijs P; van Os CH; Deen PM
    J Clin Invest; 1998 Jul; 102(1):57-66. PubMed ID: 9649557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.
    Kamsteeg EJ; Wormhoudt TA; Rijss JP; van Os CH; Deen PM
    EMBO J; 1999 May; 18(9):2394-400. PubMed ID: 10228154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.
    Chen CH; Chen WY; Liu HL; Liu TT; Tsou AP; Lin CY; Chao T; Qi Y; Hsiao KJ
    J Hum Genet; 2002; 47(2):66-73. PubMed ID: 11916004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
    Boone M; Kortenoeven M; Robben JH; Deen PM
    Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.